59 reports

TAKEDA PHARMACEUTICALS Chapter ## Appendix Acronyms List of Tables Summary Table : Global Colorectal Cancer Therapeutics Market, by Treatment Type, Through 2023 Table ## : U. S.

  • Colorectal Cancer
  • Therapy
  • World
  • Forecast
  • Market Size
  • CRC THERAPEUTICS MARKET, GLOBAL, ALL PIPELINE PRODUCTS, PRE-REGISTRATION, 2018
  • CRC THERAPEUTICS MARKET, GLOBAL, CO-DEVELOPMENT DEALS BY MOLECULE TYPE AND

CRC. ##. ## Anti-angiogenesis Therapies ##. ##. ## AVASTIN (BEVACIZUMAB) - ROCHE Avastin is a recombinant, humanized, monoclonal immunoglobulin (IgG) ## antibody developed by Roche.

  • Chemotherapy
  • Colorectal Cancer
  • Therapy
  • Market Size
  • Merck & Co., Inc.
  • Small Molecule Monoclonal Antibody
  • PIPELINE PRODUCTS - EARLY STAGE PIPELINE

HOWEVER, RECENT LAUNCHES OF ANTI- PD-## ANTIBODIES HAVE BROUGHT NEW PLAYERS TO THE MARKET.

  • Colorectal Cancer
  • China
  • United States
  • Array BioPharma Inc.
  • Eli Lilly & Co.

Colorectal Cancer Drugs/ Therapeutic Market Size, Share & Trends Analysis Report by Drug Class, By Country And Segment Forecasts, 2016 - 2022 Chapter ## Research Methodology ##. ## Information Procurement ##. ## Information or Data Analysis ##. ##. ## Market formulation & validation Chapte

  • Cancer
  • Colorectal Cancer
  • Pathology
  • United States
  • Forecast
  • COUNTRY PROFILE - US
  • Disease Management

KEYTRUDA, A HUMANIZED ANTI-PD-## MONOCLONAL ANTIBODY, BINDS TO PD-## RECEPTORS AND BLOCKS THEM FROM THE INHIBITORY EFFECT OF PD-## LIGANDS, PROMOTING A T-CELL RESPONSE.

  • Colorectal Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

It is a humanized monoclonal IgG## that binds to vascular endothelial growth factor (VEGF)-A, preventing the ligand from binding to the VEGF receptor.

  • Colorectal Cancer
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

Cyramza

8770 10000 7800

Cyramza ## OVERVIEW ## Drug Overview ## Product Profiles ## Cyramza : Hepatocellular carcinoma (HCC) ## Cyramza : Non-small cell lung cancer (NSCLC) ## Cyramza : Gastric cancer ## Cyramza : Colorectal cancer (CRC) ## Cyramza : Bladder cancer LIST OF FIGURES ## Figure ##: Datamonitor Hea

  • Colorectal Cancer
  • Hepatitis
  • European Union
  • Japan
  • United States

Colorectal Cancer: Update Bulletin ### This edition presents the views and insights from three world leading key opinion leaders (KOLs) from North America and Europe on a variety of recent events in the colorectal cancer (CRC) market, including; Symphogen announcing detailed results from its

  • Colorectal Cancer
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • Europe

Drug analysis: Vectibix Product Profiles Vectibix : Colorectal cancer (CRC) LIST OF FIGURES Figure ##: Vectibix for colorectal cancer – SWOT analysis Figure ##: Datamonitor Healthcare’s drug assessment summary of Vectibix for colorectal cancer Figure ##: Datamonitor Healthcare’s drug assessme

  • Colorectal Cancer
  • Monoclonal Antibody
  • European Union
  • Japan
  • United States

Drug analysis: Erbitux

8770 10000 7800

Erbitux may also induce the activation of the immune system through antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity.

  • Colorectal Cancer
  • European Union
  • Japan
  • United States
  • Supply

Drug analysis: Cyramza

8770 10000 7800

Drug analysis: Cyramza Product Profiles Cyramza : Colorectal cancer (CRC) Cyramza : Hepatocellular carcinoma (HCC) Cyramza : Bladder cancer Cyramza : Non-small cell lung cancer (NSCLC) Cyramza : Gastric cancer LIST OF FIGURES Figure ##: Cyramza for colorectal cancer – SWOT analysis Figure ##

  • Colorectal Cancer
  • European Union
  • Japan
  • United States
  • Supply

Colorectal cancer

4385 5000 3900
  • ZALTRAP DRUG PROFILE
  • XILONIX DRUG PROFILE

Keytruda is a humanized monoclonal antibody designed to inhibit the PD-## co-inhibitory receptor.

  • Colorectal Cancer
  • European Union
  • Japan
  • North America
  • United States
  • Introduction

Three monoclonal antibodies (mAb) - Avastin (bevacizumab), Erbitux (cetuximab) and Vectibix (panitumumab) - are currently available for the treatment of CRC, with similar degrees of efficacy and strong safety and tolerability profiles.

  • Cancer
  • Colorectal Cancer
  • Pathology
  • Therapy
  • Roche Group
  • REFERENCES

Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe.

  • Colorectal Cancer
  • Italy
  • North America
  • South America
  • Southern Europe

Monoclonal antibody acts by inhibiting MUC##.

  • Cancer
  • Colorectal Cancer
  • Vaccine
  • United States
  • Product Initiative
  • 19.1 Competitive Scenario

It is a monoclonal antibody, and works by the inhibition of EGFR.

  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Merck Serono S.A.
  • INFORMATION ON PIPELINE CANDIDATES
  • Vendor landscape

It is a monoclonal antibody and acts by inhibiting EGFR.

  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Sanofi S.A.

FDA APPROVED PHARMACOGENOMICS TESTS Herceptin BLA ## PATHWAY ANTI-HER-##/ NEU (##B##) Rabbit Monoclonal Primary Antibody Ventana Medical Systems, Inc.

  • Colorectal Cancer
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.

FDA APPROVED PHARMACOGENOMICS TESTS Herceptin BLA ## PATHWAY ANTI-HER-##/ NEU (##B##) Rabbit Monoclonal Primary Antibody Ventana Medical Systems, Inc.

  • Colorectal Cancer
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Colorectal Cancer
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • Etubics Corporation
  • 7.3 United States - Liquid Biopsy Colorectal Cancer Treatment

Mutations in the KRAS gene have been shown to be predictive to resistance to anti-EGFR monoclonal antibodies, such as Vectibix® (panitumumab) from Amgen Inc. and Erbitux® (cetuximab) from Eli Lilly and Company.

  • Colorectal Cancer
  • North America
  • United States
  • Forecast
  • Biocept, Inc.
  • DK-001 - Drug Profile

Similarly, the universities portfolio in Phase II, Phase I and Preclinical stages comprises ##, ## and ## molecules, respectively.

  • Colorectal Cancer
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Etubics Corporation

NA : Not Available Source: Global Markets Direct MONOCLONAL ANTIBODY TO INHIBIT MUC## FOR ONCOLOGY - DRUG PROFILE MONOCLONAL ANTIBODY TO INHIBIT MUC## FOR ONCOLOGY MINERVA BIOTECHNOLOGIES CORP Drug Name Company/ Institute Name Licensed From Company Development P

  • Colorectal Cancer
  • Oncology
  • United States
  • Company Operations
  • Product Initiative

Its omnirat is an antibody platform that generates human monoclonal antibodies based on transgenic rats.

  • Colorectal Cancer
  • Medical Biotechnology
  • United States
  • Company
  • Symphogen A/S
  • MAR 02, 2016: XBIOTECH TO DELIVER PRESENTATION ON NOVEL STUDY DESIGN AND PHASE III RESULTS FROM EUROPEAN STUDY ON XILONIX DURING MEETING AT THE EUROPEAN PARLIAMENT
  • JUL 02, 2016: XBIOTECH PRESENTS PIVOTAL PHASE III DATA SHOWING XILONIX DEMONSTRATED SIGNIFICANT CLINICAL RESPONSE IN ADVANCED COLORECTAL CANCER PATIENTS REFRACTORY TO FURTHER TREATMENT

" We believe these data demonstrate that our True Human monoclonal antibody targeting interleukin-## alpha has the potential to meet this critical need. "

  • Colorectal Cancer
  • Pharmaceutical
  • Europe
  • World
  • XBiotech Inc.
  • Aug 10, 2017: Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and Business Update

Syndax also develops SNDX-##, a monoclonal antibody that targets the CSF-## receptor.

  • Colorectal Cancer
  • Pharmaceutical
  • United States
  • Company
  • Syndax Pharmaceuticals, Inc.
  • PIPELINE BY ABBVIE INC, H1 2018

HGS-ETR## IS A HUMAN MONOCLONAL ANTIBODY TO TRAIL RECEPTOR ##, A PROTEIN INVOLVED IN PROGRAMMED CELL DEATH (APOPTOSIS).

  • Colorectal Cancer
  • Hospital
  • Medical Biotechnology
  • Monoclonal Antibody
  • GlaxoSmithKline plc

OWING TO THIS, THE ADMINISTRATION OF IMMUNOTHERAPY DRUGS SUCH AS MONOCLONAL ANTIBODIES, INTERFERONS, AND INTERLEUKINS RESULTS IN BETTER TREATMENT RESULTS AS COMPARED TO SMALL MOLECULES.

  • Colorectal Cancer
  • Molecular Diagnostics
  • North America
  • United States
  • Roche Group
  • PANC-DX - COLON CANCER - PRODUCT DESCRIPTION
  • ONCONOSTICA - PRODUCT DESCRIPTION

Its products include monoclonal antibodies, monoclonal antibodies to cancer-associated PTM structures, peptides and PTM-peptides.

  • Clinical Trial
  • Colorectal Cancer
  • Drug Development
  • United States
  • Company

It is a monoclonal antibody.

  • Colorectal Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.